{"entity":{"id":"jama-internal-medicine","kind":"journal","name":"JAMA Internal Medicine","aka":["JAMA Intern Med","Archives of Internal Medicine"],"tldr":"JAMA Internal Medicine is the JAMA Network's internal-medicine journal, known for sceptical, evidence-based analyses of overdiagnosis, surrogate endpoints and low-value care in cancer.","summary":"JAMA Internal Medicine was formerly Archives of Internal Medicine (renamed 2013). It is home to the 'Less Is More' series and of influential critiques of oncology evidence, including Prasad and colleagues' 2015 review of surrogate endpoints in cancer drug approvals, plus prevention studies such as the PREDIMED breast-cancer analysis. Hybrid access.","asOf":"2026-09-09","links":[{"label":"Less Is More series","url":"https://jamanetwork.com/collections/44045/less-is-more"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["overdiagnosis","screening","surrogate-endpoint","de-escalation"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"American Medical Association (JAMA Network)","url":"https://jamanetwork.com/journals/jamainternalmedicine","issn":"2168-6106","scope":"general medicine","access":"hybrid","founded":1908,"impactFactor":{"value":22.5,"year":2023,"source":"Clarivate Journal Citation Reports 2024 (2023 JIF)"},"matchNames":["JAMA Internal Medicine","JAMA Intern Med"],"society":"American Medical Association"},"route":"/journals/jama-internal-medicine/","neighbours":{"term":[{"id":"de-escalation","kind":"term","name":"De-escalation, escalation and response-adapted therapy","route":"/terms/de-escalation/"},{"id":"overdiagnosis","kind":"term","name":"Overdiagnosis","route":"/terms/overdiagnosis/"},{"id":"screening","kind":"term","name":"Screening","route":"/terms/screening/"},{"id":"surrogate-endpoint","kind":"term","name":"Surrogate endpoint","route":"/terms/surrogate-endpoint/"}],"paper":[{"id":"paper-gyawali-jama-intern-med","kind":"paper","name":"Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated Approval","route":"/key-papers/paper-gyawali-jama-intern-med/"},{"id":"paper-van-nimwegen-cardiovascular-disease-after-hodgkin-jama-intern-med-2015","kind":"paper","name":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","route":"/key-papers/paper-van-nimwegen-cardiovascular-disease-after-hodgkin-jama-intern-med-2015/"},{"id":"paper-prasad-surrogate-endpoints-jama-im-2015","kind":"paper","name":"Prasad: most surrogate endpoints in cancer trials correlate poorly with survival","route":"/key-papers/paper-prasad-surrogate-endpoints-jama-im-2015/"},{"id":"paper-predimed-breast-jama-im-2015","kind":"paper","name":"PREDIMED: a Mediterranean diet with extra-virgin olive oil and fewer breast cancers","route":"/key-papers/paper-predimed-breast-jama-im-2015/"}],"person":[{"id":"joseph-ross","kind":"person","name":"Joseph S. Ross","route":"/people/joseph-ross/"}]}}